(Q33858430)

29 July 2017

1 reference

title

Importance of angiogenesis in reproductive physiology (English)

1 reference

29 July 2017

0 references

Jaffe RB

1 reference

29 July 2017

publication date

1 February 2000

1 reference

29 July 2017

published in

Seminars in Perinatology

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

79-81

1 reference

Angiogenesis in the human female reproductive tract

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980062-2

7 January 2021

Molecular and biological properties of the vascular endothelial growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980062-2

7 January 2021

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980062-2

7 January 2021

In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980062-2

7 January 2021

Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980062-2

7 January 2021

Vascular endothelial growth factor is essential for corpus luteum angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980062-2

7 January 2021

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980062-2

7 January 2021

Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980062-2

7 January 2021

Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980062-2

7 January 2021

10.1016/S0146-0005(00)80062-2

Identifiers

DOI

1 reference

29 July 2017

1 reference